New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

LONDON (Reuters) - Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as to whether this scientific success will ...

Merck & Co. Inc. MRK on Wednesday announced a strategic collaboration with Mayo Clinic to leverage artificial intelligence (AI) and advanced analytics in drug discovery. This partnership aims to ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo March 30 (Reuters) - Merck's oral drug reduced bad ...

Merck has FDA approval for a new combination drug for HIV, giving patients a new treatment option and an alternative to a blockbuster Gilead Sciences pill that comes with tolerability and side effect ...

Merck is picking up a big new piece for its cancer drug pipeline with a $6.7 billion deal to acquire Terns Pharmaceuticals, a company whose lead program could rival a blockbuster product from Novartis ...

Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons ...

Merck KGaA has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology – marking the first big ...